newsfilter
← Latest News
PR Newswire·

Protalix BioTherapeutics Added to Russell 3000® and 2000 Indexes®

Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development, production and commercialization of...